HUYA Bioscience International, LLC(製薬・医療分野):企業M&A動向

【英語タイトル】HUYA Bioscience International, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDPH140773D)・商品コード:GDPH140773D
・発行会社(調査会社):GlobalData
・発行日:2015年3月25日
・ページ数:31
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アメリカ
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

HUYA Bioscience International, LLC (HUYA) is a biopharmaceutical company. It develops pre-clinical and clinical drug candidates and accelerates the global development of biopharmaceutical product opportunities originating in China. It offers products in the areas of cardiology, gastroenterology, hematology, immunology, infectious diseases, metabolic diseases, musculoskeletal diseases, neurology, oncology and psychiatry. HUYA’s product pipeline includes HBI-3000 for the treatment of arrhythmias; and HBI-8000 an oncology compound. The company identifies and licenses the pre-clinical and clinical stage compounds in China. It operates through seven offices located in China. The company partners with Quintiles, Abbott and Solvay for co-developing its in-licensed therapeutic drug candidates and compound access collaborations. HUYA is headquartered in San Diego, California, the US.

HUYA Bioscience International, LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Huya Bioscience Raises US$4.6 Million In Series B Financing 11
Partnerships 12
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 12
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 13
HUYA Bioscience Enters Into Co-Development Agreement With Tianjin International 14
HUYA Bioscience Enters Into Co-Development Agreement With Zhejiang Chinese Medical University Life Science College 15
HUYA Bioscience Enters Into Co-Development Agreement With Shanghai Jiao Tong 16
HUYA Bioscience International Enters Into An Agreement With Zhongshan National Health 17
HUYA Bioscience International Enters Into Collaboration With Wuhan National Bio-industry 18
HUYA Bioscience Enters Into Co-Development Agreement With Quintiles Transnational 19
HUYA Bioscience Enters Into Co-Development Agreement With Sun Yat-sen University 21
HUYA Bioscience Enters Into Co-Promotion Agreement With China Medical City 22
HUYA Bioscience Enters Into Agreement With Ocean University of China 23
HUYA Bioscience Enters Into Co-Development Agreement With Guangzhou Institutes 24
HUYA Bioscience Enters Into Co-Development Agreement With Shenyang Pharma University 25
Solvay Pharma Signs An Agrrement With HUYA 26
HUYA Bioscience Enters Into Co-Development Agreement With Abbott 27
HUYA Bioscience International, LLC – Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Key Facts 1
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
HUYA Bioscience International, LLC, Deals By Therapy Area, 2009 to YTD 2015 8
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Huya Bioscience Raises US$4.6 Million In Series B Financing 11
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 12
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 13
HUYA Bioscience Enters Into Co-Development Agreement With Tianjin International 14
HUYA Bioscience Enters Into Co-Development Agreement With Zhejiang Chinese Medical University Life Science College 15
HUYA Bioscience Enters Into Co-Development Agreement With Shanghai Jiao Tong 16
HUYA Bioscience International Enters Into An Agreement With Zhongshan National Health 17
HUYA Bioscience International Enters Into Collaboration With Wuhan National Bio-industry 18
HUYA Bioscience Enters Into Co-Development Agreement With Quintiles Transnational 19
HUYA Bioscience Enters Into Co-Development Agreement With Sun Yat-sen University 21
HUYA Bioscience Enters Into Co-Promotion Agreement With China Medical City 22
HUYA Bioscience Enters Into Agreement With Ocean University of China 23
HUYA Bioscience Enters Into Co-Development Agreement With Guangzhou Institutes 24
HUYA Bioscience Enters Into Co-Development Agreement With Shenyang Pharma University 25
Solvay Pharma Signs An Agrrement With HUYA 26
HUYA Bioscience Enters Into Co-Development Agreement With Abbott 27
HUYA Bioscience International, LLC, Key Competitors 28
HUYA Bioscience International, LLC, Key Employees 29
HUYA Bioscience International, LLC, Other Locations 30
HUYA Bioscience International, LLC, Subsidiaries 30

List of Figures
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
HUYA Bioscience International, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★調査レポート[HUYA Bioscience International, LLC(製薬・医療分野):企業M&A動向] (コード:GDPH140773D)販売に関する免責事項を必ずご確認ください。
★調査レポート[HUYA Bioscience International, LLC(製薬・医療分野):企業M&A動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆